A retrospective study published in The American Journal of Gastroenterology linked the use of statins to a reduced risk of nonalcoholic fatty liver disease and liver fibrosis. The study, conducted by Jung Il Lee, MD, PhD, and colleagues at Yonsei University College of Medicine in South Korea, gleaned data on patients with NAFLD and those without it from the National Health Information Database of the Republic of Korea. Read the abstract.
Study links statin use to lower NAFLD, fibrosis risks
Sign up for ACG SmartBrief
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.